Summary
This edition of Clinical Evidence reviews adherence to remote monitoring (RM) recommendations in CIEDs follow-up and innovations to enhance this technology, focusing on Heart Connect's preliminary experience. It also explores findings from a sub-analysis of the PRAETORIAN study.
An analysis¹ of LATITUDE™ RM system data shows growing RM use but highlights critical aspects for effective clinical practice with high volumes of visits. Heart Connect, a real-time remote technical support service, has proven² feasible, effective, and well-accepted for providing prompt support during in-person CIED follow-up. The PRAETORIAN sub-analysis³ demonstrated comparable rates of inappropriate therapies between S-ICD and TV-ICD in the conventional ICD population, though these results should be reconsidered with recent S-ICD advancements.
Key Takeaways
- Adherence to remote monitoring guidelines for CIEDs in clinical practice: RM use is growing in clinical practice, but critical issues remain for its effectiveness, efficiency, and sustainability in real-life. To address these challenges and improve its use, innovative solutions have been introduced to support physicians¹.
- Real-time Remote Technical Support for CIED Follow-up: Remote support using HeartConnect™ during CIED follow-up proved feasible, effective, and well-accepted by operators, offering a viable alternative to on-site IEAPs support for follow-up visits².
- Insights from the PRAETORIAN Trial: This multicenter randomised study found no significant difference in inappropriate therapy rates and IAS rates between the S-ICD and TV-ICD in a conventional ICD population³.
Gain deeper insights by downloading the full newsletter
